The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting Strategies
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference48 articles.
1. Practical Applications of Nuclear Medicine in Imaging Breast Cancer
2. Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts
3. Single-chain antibody-based gene therapy: inhibition of tumor growth by in situ production of phage-derived human antibody fragments blocking functionally active sites of cell-associated matrices
4. Affibody-mediated tumour targeting of HER-2 expressing xenografts in mice
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse;Blood;2023-02-16
2. gC1qR: A New Target for Cancer Immunotherapy;Frontiers in Immunology;2023-01-26
3. C1QBP Mediates Breast Cancer Cell Proliferation and Growth via Multiple Potential Signalling Pathways;International Journal of Molecular Sciences;2023-01-10
4. C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response;Frontiers in Physiology;2022-11-17
5. An approach to p32/gC1qR/HABP1: a multifunctional protein with an essential role in cancer;Journal of Cancer Research and Clinical Oncology;2022-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3